Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Source: PRNewswire· August 6, 2026
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
SynaBot summary

Clarivate is integrating agentic AI into its Cortellis platform, aiming to speed up drug development. This move empowers life sciences companies to translate complex data into actionable insights, streamlining the entire research and development process.

Key takeaways

  • Agentic AI now active within Cortellis platform
  • Focus on accelerating drug development cycles
  • Empowers data-driven decision-making in R&D
  • Transforms intelligence into actionable steps

Why it matters

For professionals in life sciences, this means AI assistants can now proactively analyze vast datasets and suggest next steps in drug discovery. It shifts AI from a passive information source to an active partner in accelerating critical research timelines.

This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire

Try this on SynaBot

Related AI assistants, prompts, and tools from the SynaBot catalog.

More in AI Research

View all